Raising the issue during Zero Hour, P Rajeeve (CPI-M) said common man was suffering due to hike in prices of essential medicines used to treat tuberculosis, AIDS, diabetes and heart ailments.
He said the price of anti-cancer drug Glivec has gone up from Rs 8,500 to Rs 1.08 lakh while rates of Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615 against Rs 147 earlier. Anti-rabies injection, Kamrab, priced at Rs 2,670 will now cost Rs 7,000.
He said the price shot up after the government directed the National Pharmaceutical Pricing Authority (NPPA), an autonomous body, to withdraw its May 2014 guidelines on drug price control.
"This has happened because of pressure of pharmaceutical companies," he alleged, adding the government is working for monopolies and is totally against common man.
NPPA had capped the prices of these 108 drugs, in addition to the already listed 800 essential drugs, to improve their affordability.
Members for almost all opposition parties associated themselves with the issue.
Anand Sharma (Cong) said the issue raised is a serious matter and there should be a discussion on it in the House.
Noting that the issue concerns poor people who do not have access to life saving medicines, he said, "The House must take note of it and discuss it urgently."
Sitaram Yechury (CPI-M) wanted the government to give an assurance that it will get back to the House on the issue.
Deputy Chairman P J Kurien said it was for the government to respond and he cannot compel it to do so.
Sharad Yadav (JD-U) said a debate is required on the serious issue.
Minister of State for Parliamentary Affairs Mukhtar Abbas Naqvi said the anguish of the members will be conveyed to the minister concerned.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)